TP53 and breast cancer: We examined the effects of OME on cell viability, cell cycle, apoptosis, and the levels of several cell cycle and apoptosis control proteins in the highly proliferative and invasive Estrogen Receptor (ER)-negative, mutant p53 breast cancer cell lines MDA-MB-231.